消融局部驱动源治疗心房颤动的临床获益:印第安纳大学FIRM注册研究
本研究为印第安纳大学连续170例房颤患者的注册研究,采用FIRM标测与消融。结果显示右心房源见于85%、左心房源见于90%的患者;单次FIRM消融后1年无房颤率在阵发性、持续性、长程持续性房颤中分别为95%、83%、82%,结论认为FIRM引导消融单次成功率较高,但需随机试验验证。
要点
- FIRM标测显示右心房源见于85%、左心房源见于90%的房颤患者。
- FIRM消融终止房颤的比例:阵发性59%、持续性37%、长程持续性19%。
- 单次FIRM术后1年无房颤率:阵发性95%、持续性83%、长程持续性82%。
核心结论
- 在印第安纳大学FIRM注册研究中,FIRM引导消融产生较高的单次手术成功率,主要见于非阵发性房颤患者。
- 标测、急性终止和结局数据强烈支持双心房转子与局灶源在多种人群中维持房颤的机制作用。
- 需要FIRM引导消融的随机试验以及确定转子如何形成、进展和消退的机制研究。
研究设计与样本
- 研究为印第安纳大学连续170例接受源标测的房颤患者注册分析,平均年龄59±12岁,79%为男性。
- 患者中阵发性房颤占37%、持续性房颤占31%、长程持续性房颤占32%。
- 73例(43%)既往至少接受过1次消融尝试(平均1.9±0.8次,范围1至4次)。
- 所有病例均使用心内膜篮状导管进行局灶冲动与转子调制(FIRM)。
主要发现
- FIRM分析显示右心房源见于85%的患者(1.8±1.3个),左心房源见于90%的患者(2.0±1.3个)。
- FIRM消融使房颤终止为窦性心律、心房扑动或心动过速的比例分别为阵发性59%、持续性37%、长程持续性19%,67次终止中15次由右心房消融所致。
- 整个系列单次FIRM术后1年无房颤率分别为阵发性95%、持续性83%、长程持续性82%。
- 单次FIRM术后1年无任何房性心律失常率分别为阵发性77%、持续性75%、长程持续性57%。
临床怎么用
- 原文结论指出FIRM引导消融产生较高的单次手术成功率,主要见于非阵发性房颤患者。
- 原文认为需要FIRM引导消融的随机试验以及确定转子如何形成、进展和消退的机制研究。
局限性
- 原文结论指出需要FIRM引导消融的随机试验以及确定转子如何形成、进展和消退的机制研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mounting evidence shows that localized sources maintain atrial fibrillation (AF). However, it is unclear in unselected "real-world" patients if sources drive persistent atrial fibrillation (PeAF), long-standing persistent atrial fibrillation (LPeAF), or paroxysmal atrial fibrillation (PAF); if right atrial sites are important; and what the long-term success of source ablation is. OBJECTIVES: The aim of this study was to analyze the role of rotors and focal sources in a large academic registry of consecutive patients undergoing source mapping for AF. METHODS: One hundred seventy consecutive patients (mean age 59 ± 12 years, 79% men) with PAF (37%), PeAF (31%), or LPeAF (32%). Of these, 73 (43%) had undergone at least 1 prior ablation attempt (mean 1.9 ± 0.8; range: 1 to 4). Focal impulse and rotor modulation (FIRM) with an endocardial basket catheter was used in all cases. RESULTS: FIRM analysis revealed sources in the right atrium in 85% of patients (1.8 ± 1.3) and in the left atrium in 90% of patients (2.0 ± 1.3). FIRM ablation terminated AF to sinus rhythm or atrial flutter or tachycardia in 59% (PAF), 37% (PeAF), and 19% (LPeAF) of patients, with 15 of 67 terminations due to right atrial ablation. On follow-up, freedom from AF after a single FIRM procedure for the entire series was 95% (PAF), 83% (PeAF), and 82% (LPeAF) at 1 year and freedom from all atrial arrhythmias was 77% (PAF), 75% (PeAF), and 57% (LPeAF). CONCLUSIONS: In the Indiana University FIRM registry, FIRM-guided ablation produced high single-procedure success, mostly in patients with nonparoxysmal AF. Data from mapping, acute terminations, and outcomes strongly support the mechanistic role of biatrial rotors and focal sources in maintaining AF in diverse populations. Randomized trials of FIRM-guided ablation and mechanistic studies to determine how rotors form, progress, and regress are needed.
引用
- Miller JM, Kalra V, Das MK, et al. Clinical Benefit of Ablating Localized Sources for Human Atrial Fibrillation: The Indiana University FIRM Registry. J Am Coll Cardiol. 2017. PMID: 28279291. doi:10.1016/j.jacc.2016.11.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。